Methodological issues in evaluating measures of health as outcomes for COPD

European Respiratory Journal, Supplement

Volumn 21, Issue 41, 2003, Pages

  Jones, P W ^a   Kaplan, R M ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Health status; Measurement standardisation; Outcome measures; Utility based measures

Indexed keywords

CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; HEALTH STATUS; HUMAN; MEASUREMENT; METHODOLOGY; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; STANDARD; AGED; FEMALE; HOSPITALIZATION; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PROGNOSIS; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TREATMENT OUTCOME;

EID: 0038440793     PISSN: 09041850     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (62)

1. Kaplan RM. Behavior as the central outcome in health care. Am Psychol 1990; 45: 1211-1220.
2. Kaplan RM. The Ziggy theorem: toward an outcomes-focused health psychology. Health Psychol 1994; 13: 451-460.
3. Kaplan RM. Measuring health outcomes for resource allocation. In: Glueckauf E, Robert G, Frank E, eds. Psychological Practice in a Changing Health Care System: Issues and New Directions. New York, Springer Publishing Co., Inc., 1996; pp. 101-133
4. Carone M, Ambrosino N, Bertolotti G, et al. Quality of life evaluation and survival study: a 3-yr prospective multinational study on patients with chronic respiratory failure. Monaldi Arch Chest Dis 2001; 56: 17-22.
5. Squier HC, Ries AL, Kaplan RM, et al. Quality of wellbeing predicts survival in lung transplantation candidates. Am J Respir Crit Care Med 1995; 152: 2032-2036.
6. Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM. Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. Chest 1998; 113: 619-624.
7. Eakin EG, Sassidambron DE, Ries AL, Kaplan RM. Reliability and validity of dyspnea measures in patients with obstructive lung disease. Int J Behav Med 1995; 2: 118-134.
8. Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol 1999; 52: 187-192.
9. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax 2001; 56: 880-887.
10. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404.
11. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. Qual Life, Res 1993; 2: 467-475.
12. Orenstein DM, Kaplan RM. Measuring the quality of wellbeing in cystic fibrosis and lung transplantation - the importance of the area under the curve. Chest 1991; 100: 1016-1018.
13. Russell LB. Improving the panel's recommendations. Med Decis Making 1999; 19: 374-383.
14. Russell LB. The methodologic partnership of effectiveness reviews and cost-effectiveness analysis. Am J Prev Med 2001; 20: Suppl. 3, 10-12.
15. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1253-1258.
16. Soderman P, Malchau H, Herberts P. Outcome after total hip arthroplasty: Part I. General health evaluation in relation to definition of failure in the Swedish National Total Hip Arthroplasty register. Acta Orthop Scand 2000; 71: 354-359.
17. O'Connell T, Browne C, Corcoran R, Howell F. Quality of life following total hip replacement. Ir Med J 2000; 93: 108-110.
18. March LM, Cross MJ, Lapsley H, et al. Outcomes after hip or knee replacement surgery for osteoarthritis. A prospective cohort study comparing patients' quality of life before and after surgery with age-related population norms. Med J Aus 1999; 171: 235-238.
19. Mangione CM, Goldman L, Orav EJ, et al. Health-related quality of life after elective surgery: measurement of longitudinal changes. J Gen Intern Med 1997; 12: 686-697.
20. Boardman DL, Dorey F, Thomas BJ, Lieberman JR. The accuracy of assessing total hip arthroplasty outcomes: a prospective correlation study of walking ability and 2 validated measurement devices. J Arthroplasty 2000; 15: 200-204.
21. tenHove M, Siegel K, Groll D, Hopman W. Evaluating the quality of life in patients undergoing surgery to restore bilateral sight. Ann Meet Int Soc Technol Assess Health Care 1998; 14: 83.
22. Hove MT, Seigel K, Groll D, Hopman W, MacKenzie T. The measurement of quality of life in patients with unilateral visual impairment. Abst Book Assoc Health Services Res 1998; 15: 187.
23. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 1995; 122: 823-832.
24. Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51: 903-912.
25. Kaplan RM, Sieber WJ, Ganiats TG. The Quality of Well-Being Scale: Comparison of the interviewer-administered version with a self-administered questionnaire. Psychol Health 1997; 12: 783-791.
26. Jones PW. Issues concerning health-related quality of life in COPD. Chest 1995; 107: Suppl. 5, 187S-193S.
27. Belman MJ, Botnick WC, Shin JW. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153: 967-975.
28. O'Donnell DE, Webb KA. Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation. Am Rev Respir Dis 1993; 148: 1351-1357.
29. Kaplan RM. Using quality of life information to set priorities in health policy. Soc Indicat Res 1994; 33: 121-163.
30. Eakin EG, Kaplan RM, Ries AL, Sassidambron DE. Patients' self-reports of dyspnea - an important and independent outcome in chronic obstructive pulmonary disease. Ann Behav Med 1996; 18: 87-90.
31. Carone M, Donner CF, Jones PW. Health status measurement: an increasingly important outcome evaluation in COPD patients. Monaldi Arch Chest Dis 2001; 56: 297-298.
32. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724-735.
33. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805.
34. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984; 37: 85-95.
35. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145: 1321-1327.
36. Kaplan RM. An outcomes-based model for directing decisions in women's health care. Clin Obstel Gynecol 1994; 37: 192-206.
37. Kaplan RM. Two pathways to prevention. Am Psychol 2000; 55: 382-396.
38. Kaplan RM, Ganiats TG, Sieber WJ, Anderson JP. The quality of well-being scale: critical similarities and differences with SF-36. Int J Qual Health Care 1998; 10: 509-520.
39. Kaplan RM, Mehta R. Outcome measurement in kidney disease. Blood Purif 1994; 12: 20-29.
40. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54: 581-586.
41. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-758.
42. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
43. Guyatt GH, Deyo RA, Charlson M, Levine MN, Mitchell A. Responsiveness and validity in health status measurement: a clarification. J Clin Epidemiol 1989; 42: 403-409.
44. Guyatt GH, Tugwell PX, Feeny DH, Drummond MF, Haynes RB. The role of before-after studies of therapeutic impact in the evaluation of diagnostic technologies. J Chronic Dis 1986; 39: 295-304.
45. Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 1986; 39: 897-906.
46. Hays RD, Woolley JM. The concept of clinically meaningful difference in health-related quality-of-life research. How meaningful is it? Pharmacoeconomics 2000; 18: 419-423.
47. Redelmeier DA, Guyatt GH, Goldstein RS. Assessing the minimal important difference in symptoms: a comparison of two techniques. J Clin Epidemiol 1996; 49: 1215-1219.
48. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155: 1278-1282.
49. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-415.
50. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: Suppl. B, 25-33.
51. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
52. Barley EA, Jones PW. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. Eur Respir J 1999; 14: 591-596.
53. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
54. Gold MR. Cost-Effectiveness in Health and Medicine. New York, Oxford University Press, 1996.
55. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC. The role of cost-effectiveness analysis in health and medicine. Panel on cost-effectiveness in health and medicine. JAMA 1996; 276: 1172-1177.
56. Kind P. The performance characteristics of EQ-5D, a measure of health related quality of life for use in technology assessment. Ann Meet Int Soc Technol Assess Health Care 1997; 13: 81.
57. Feeny D, Furlong W, Boyle M, Torrance GW. Multiattribute health status classification systems. Health Utilities Index. Pharmacoeconomics 1995; 7: 490-502.
58. Gudex C, Dolan P, Kind P, Williams A. Health state valuations from the general public using the visual analogue scale. Qual Life Res 1996; 5: 521-531.
59. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-559.
60. Feeny D, Furlong W, Mulhern RK, Barr RD, Hudson M. A framework document for assessing health-related quality of life among children with cancer. Int J Cancer Suppl 1999; 12: 2-9.
61. Kaplan RM, Anderson JP, Pattersnon TL, et al. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center. Psychosom Med 1995; 57: 138-147.
62. Kaplan RM, Feeny D, Revicki DA. Methods for assessing relative importance in preference based outcome measures. In: Joyce CR, O'Boyle CA, McGee HM, eds. Individual Quality of Life: Approaches to Conceptualisation and Assessment. The Netherlands, Hardwood Academic Publishers, 1999; pp. 135-149.